SCHEMBL14740755

SCHEMBL14740755

O=C(O)Nc1ccc(Br)cc1NC(=O)CC(=O)N1C=CC=NC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
GAA P10253 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 2/20 0.36
KMT2A Q03164 7/20 0.36
MEN1 O00255 6/20 0.36
POLB P06746 2/20 0.36
HSD17B10 Q99714 1/20 0.35
AAK1 Q2M2I8 1/20 0.35
GRK2 P25098 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
USP2 O75604 1/20 0.33
PKM P14618 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14740754 0.76 ALDH1A1 (0.37) ALDH1A1GAATDP1KDM4ENPC1
SCHEMBL14053110 0.71 ALDH1A1 (0.47) ALDH1A1GAATDP1KDM4ENPC1
SCHEMBL14740818 0.66 STING1 (0.42) ALDH1A1GAATDP1KDM4ENPC1
SCHEMBL14740843 0.64 KMT2A (0.53) ALDH1A1GAAKDM4ENPC1KMT2A
SCHEMBL2491853 0.64 LMNA (0.66) ALDH1A1GAATDP1KDM4ENPC1
SCHEMBL17336575 0.64 RAB9A (0.43) ALDH1A1GAATDP1KDM4ENPC1
SCHEMBL15559293 0.61 AAK1 (0.55) ALDH1A1KDM4ENPC1POLBAAK1
SCHEMBL17498094 0.61 NPC1 (0.49) ALDH1A1GAANPC1KMT2AMEN1
SCHEMBL933257 0.60
SCHEMBL12479615 0.60 MAPK1 (0.56) ALDH1A1GAATDP1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751095-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF Sanford-Burnham Medical Research Institute (US) 2014-07-09 EP disclosed
WO-2013033246-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF BRAINCELLS, INC. (US) 2013-03-07 WO disclosed